<http://schema.org/description>
"Cancer therapies often have short-lived benefits due to the emergence of genetic mutations that cause drug resistance. A key gene that determines resistance to a range of cancer drugs has been reported in a study published by Cell Press November 21st in the journal Cell. The study reveals a biomarker that can predict responses to cancer drugs and offers a strategy to treat drug-resistant tumors based on their genetic signature."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2012-11-drug-resistance-biomarker-cancer-treatment.html>